| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $6.24M | $9.66M | $23.35M | $3.69M | $2.16M |
| R&D | – | – | – | – | – |
| SG&A | $336.09K | $343.55K | $341.98K | $140.68K | $138.29K |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$6.23M | -$10.17M | -$23.11M | -$3.69M | -$2.16M |
| EPS (basic) | 0.0000 | 0.0000 | -0.0100 | 0.0000 | 0.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | -0.0100 | – | – |
| Shares (diluted) | $3.66B | $3.24B | $2.41B | $1.98B | – |